Dopamine and NMDA: role in novelty detection

多巴胺和 NMDA:在新颖性检测中的作用

基本信息

  • 批准号:
    7858385
  • 负责人:
  • 金额:
    $ 25.68万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-06-01 至 2011-05-31
  • 项目状态:
    已结题

项目摘要

Both NMDA hypofunction and dopamine hyperfunction have been implicated in Schizophrenia. Moreover, the hippocampal region appears to be involved in the disease, perhaps because of aberrant novelty detection processes in the CA1 region. These novelty detection processes may depend on predictions arriving at CA1 from CAS via the Schaffer collaterals (SC) and sensory reality arriving directly from cortex via the perforant path (PP). It is therefore important to understand dopamine and NMDAR function in CA1, to elucidate the ways in which they contribute to pathway interactions, and to test the hypothesis that these pathway interactions indeed underlie a novelty detection process. Aim 1 seeks to understand the role of dopamine/NMDAR interactions at the SC and PP. Preliminary evidence indicates that D1 modulation can affect the NMDA conductance through a postsynaptic process, that the NMDA subunits are different in the two pathways and that D1 modulation may depend on NMDA subunit composition. This line of investigation will be continued and extended to D2 modulation. The ability to excite individual synapses using two-photon uncaging of glutamate will allow the first study of dopaminergic modulation at single dendritic spines. It will thus be possible to test whether this modulation is heterogeneous at the single spine level. Aim 2 utilizes both in vivo and in vitro approaches to test the hypothesis that pathway interactions perform a novelty detection process. Whole cell recording will be used to understand the biophysics of pathway interaction and the role of NMDAR and dopaminergic modulation in this process. Preliminary work suggests that pathway interactions can lead to supra-linear dendritic responses and that these are dependent on the NMDAR function. However, other work indicates that naturally occurring processes mediated by GABA conductances and lh can prevent (brake) the supralinearity. Experiments will be conducted to determine whether there are pathway timing conditions or neuromodulatory conditions in which the effectiveness of the brake is minimized. A supralinear response generated by an NMDA spike would be a candidate biophysical response to mediate novelty detection (a match signal). The role of dopamine in modulating these pathways (as studied in Aim 1) will also be examined. A critical need in understanding the pathway interactions studied in vitro is to obtain data about the CA1 computations that occur in vivo. In collaboration with the Center member, Howard Eichenbaum, recordings will be made from the CA1 region during the presentation of novel sequences. Multiple tetrodes will be used to test whether CA1 is a site of novelty detection, as proposed on theoretical grounds. Together these lines of investigation will help to integrate events spanning across multiple levels and elucidate how molecular defects in the NMDA and dopamine system could contribute to symptoms of schizophrenia.
NMDA功能减退和多巴胺功能亢进都与精神分裂症有关。此外,委员会认为, 海马区似乎与这种疾病有关,也许是因为异常的新奇, 在CA 1区的检测过程。这些新奇检测过程可能取决于预测 从CAS经由Schaffer侧支(SC)到达CA 1,以及从皮层经由SC直接到达感觉现实。 穿孔路径(PP)。因此,了解多巴胺和NMDAR在CA 1中的功能, 阐明它们促进途径相互作用的方式,并检验这些相互作用的假设。 途径相互作用确实是新奇检测过程的基础。目标1旨在了解 在SC和PP处的多巴胺/NMDAR相互作用。初步证据表明,D1调制可以 通过突触后过程影响NMDA电导,NMDA亚基在突触后不同, 两种途径,D1的调节可能取决于NMDA亚基的组成。这条调查线 将继续并扩展到D2调制。利用双光子激发单个突触的能力 谷氨酸盐的释放将允许在单个树突棘上的多巴胺能调节的首次研究。它将 因此可以测试这种调制在单个脊柱水平是否是异质的。目标2利用 在体内和体外的方法来测试的假设,途径相互作用执行的新奇性 检测过程。全细胞记录将用于理解通路相互作用的生物物理学, NMDAR和多巴胺能调节在这一过程中的作用。初步研究表明, 相互作用可以导致超线性树突状反应,这些都依赖于NMDAR 功能然而,其他工作表明,由GABA电导介导的自然发生的过程 并且LH可以防止(制动)超线性。将进行实验以确定是否存在 通路定时条件或神经调节条件,其中制动器的有效性是 最小化由NMDA尖峰产生的超线性响应将是候选生物物理响应 以调节新奇检测(匹配信号)。多巴胺在调节这些通路中的作用(如 (1)也将进行研究。理解研究中的途径相互作用的关键需要 体外的目的是获得关于体内发生的CA 1计算的数据。与中心合作 成员,霍华德Eichenbaum,录音将从CA 1地区在介绍小说 序列的将使用多个四极管来测试CA 1是否是新奇检测位点,如 理论基础。这些调查线将有助于整合跨越 多个水平,并阐明如何在NMDA和多巴胺系统的分子缺陷可能有助于 精神分裂症的症状。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSEPH T. COYLE其他文献

Combined Use of Tricyclic Antidepressants and Neuroleptics in the Management of Terminally 111 Children: A Report on Three Cases
  • DOI:
    10.1016/s0002-7138(09)60569-0
  • 发表时间:
    1985-07-01
  • 期刊:
  • 影响因子:
  • 作者:
    MOHAMMAD MAISAMI;BARBARA H. SOHMER;JOSEPH T. COYLE
  • 通讯作者:
    JOSEPH T. COYLE
Lesion of striatal neurons with kainic acid provides a model for Huntington's chorea
用红藻氨酸损伤纹状体神经元可提供亨廷顿舞蹈病的模型
  • DOI:
    10.1038/263244a0
  • 发表时间:
    1976-09-01
  • 期刊:
  • 影响因子:
    48.500
  • 作者:
    JOSEPH T. COYLE;ROBERT SCHWARCZ
  • 通讯作者:
    ROBERT SCHWARCZ

JOSEPH T. COYLE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSEPH T. COYLE', 18)}}的其他基金

Drug Abuse, Schizophrenia, NMDA Receptor
药物滥用、精神分裂症、NMDA 受体
  • 批准号:
    8491057
  • 财政年份:
    2013
  • 资助金额:
    $ 25.68万
  • 项目类别:
Drug Abuse, Schizophrenia, NMDA Receptor
药物滥用、精神分裂症、NMDA 受体
  • 批准号:
    8658065
  • 财政年份:
    2013
  • 资助金额:
    $ 25.68万
  • 项目类别:
Computational Core
计算核心
  • 批准号:
    8074013
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
BIOSTATISTICAL RESEARCH CORE
生物统计研究核心
  • 批准号:
    8074012
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
NMDA hypofunction and episodic memory: An animal model
NMDA 功能减退和情景记忆:动物模型
  • 批准号:
    8074007
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
Clinical Trials with Glutamatergic Agents
谷氨酸能药物的临床试验
  • 批准号:
    8074010
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
Biomarkers of NMDA dysfunction and D-serine effects
NMDA 功能障碍和 D-丝氨酸效应的生物标志物
  • 批准号:
    8074011
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
Functional MR of the Effects of D-Serine
D-丝氨酸作用的功能 MR
  • 批准号:
    8074009
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
Mouse Models of NMDAR Hypofunction
NMDAR 功能减退小鼠模型
  • 批准号:
    8074008
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:
Dopamine and NMDA: role in novelty detection
多巴胺和 NMDA:在新颖性检测中的作用
  • 批准号:
    8074006
  • 财政年份:
    2010
  • 资助金额:
    $ 25.68万
  • 项目类别:

相似海外基金

Biophysics of Branched Cells: Intracellular Transport, Scaling Laws and The Supply of Metabolic Demand
分支细胞的生物物理学:细胞内运输、缩放定律和代谢需求的供应
  • 批准号:
    2210464
  • 财政年份:
    2022
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Continuing Grant
Systems Biophysics of Multiscale State Transitions in Cells and Tissues
细胞和组织多尺度状态转变的系统生物物理学
  • 批准号:
    10461196
  • 财政年份:
    2021
  • 资助金额:
    $ 25.68万
  • 项目类别:
Systems Biophysics of Multiscale State Transitions in Cells and Tissues
细胞和组织多尺度状态转变的系统生物物理学
  • 批准号:
    10798506
  • 财政年份:
    2021
  • 资助金额:
    $ 25.68万
  • 项目类别:
Systems Biophysics of Multiscale State Transitions in Cells and Tissues
细胞和组织多尺度状态转变的系统生物物理学
  • 批准号:
    10275855
  • 财政年份:
    2021
  • 资助金额:
    $ 25.68万
  • 项目类别:
Systems Biophysics of Multiscale State Transitions in Cells and Tissues
细胞和组织多尺度状态转变的系统生物物理学
  • 批准号:
    10631113
  • 财政年份:
    2021
  • 资助金额:
    $ 25.68万
  • 项目类别:
Development of safe CAR-T cells based on logical molecular design of biophysics
基于生物物理学逻辑分子设计开发安全CAR-T细胞
  • 批准号:
    20H03639
  • 财政年份:
    2020
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
微循环中循环肿瘤细胞簇的转移和生物物理学
  • 批准号:
    9924267
  • 财政年份:
    2018
  • 资助金额:
    $ 25.68万
  • 项目类别:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
微循环中循环肿瘤细胞簇的转移和生物物理学
  • 批准号:
    10429911
  • 财政年份:
    2018
  • 资助金额:
    $ 25.68万
  • 项目类别:
Metastasis and biophysics of clusters of circulating tumor cells in the microcirculation
微循环中循环肿瘤细胞簇的转移和生物物理学
  • 批准号:
    10152522
  • 财政年份:
    2018
  • 资助金额:
    $ 25.68万
  • 项目类别:
Investigating the Biophysics of Giant Polyploidal Cancer Cells in an Aging Tumor Stroma
研究老化肿瘤基质中巨型多倍体癌细胞的生物物理学
  • 批准号:
    1825174
  • 财政年份:
    2018
  • 资助金额:
    $ 25.68万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了